These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 27324284)
1. Effect of dietary lysine restriction and arginine supplementation in two patients with pyridoxine-dependent epilepsy. Yuzyuk T; Thomas A; Viau K; Liu A; De Biase I; Botto LD; Pasquali M; Longo N Mol Genet Metab; 2016 Jul; 118(3):167-172. PubMed ID: 27324284 [TBL] [Abstract][Full Text] [Related]
2. Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: L-arginine supplementation alternative to lysine-restricted diet. Mercimek-Mahmutoglu S; Cordeiro D; Cruz V; Hyland K; Struys EA; Kyriakopoulou L; Mamak E Eur J Paediatr Neurol; 2014 Nov; 18(6):741-6. PubMed ID: 25127453 [TBL] [Abstract][Full Text] [Related]
3. Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials. van Karnebeek CD; Hartmann H; Jaggumantri S; Bok LA; Cheng B; Connolly M; Coughlin CR; Das AM; Gospe SM; Jakobs C; van der Lee JH; Mercimek-Mahmutoglu S; Meyer U; Struys E; Sinclair G; Van Hove J; Collet JP; Plecko BR; Stockler S Mol Genet Metab; 2012 Nov; 107(3):335-44. PubMed ID: 23022070 [TBL] [Abstract][Full Text] [Related]
4. A Prospective Case Study of the Safety and Efficacy of Lysine-Restricted Diet and Arginine Supplementation Therapy in a Patient With Pyridoxine-Dependent Epilepsy Caused by Mutations in ALDH7A1. Mahajnah M; Corderio D; Austin V; Herd S; Mutch C; Carter M; Struys E; Mercimek-Mahmutoglu S Pediatr Neurol; 2016 Jul; 60():60-5. PubMed ID: 27212567 [TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical outcome of a patient with pyridoxine-dependent epilepsy treated by triple therapy (pyridoxine supplementation, lysine-restricted diet, and arginine supplementation). Minet P; Sarret C; Miret A; Mention K; Benoist JF; Remerand G Acta Neurol Belg; 2021 Dec; 121(6):1669-1675. PubMed ID: 33113107 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate, pipecolic acid and alpha-aminoadipic acid in pyridoxine-dependent epilepsy. Xue J; Wang J; Gong P; Wu M; Yang W; Jiang S; Wu Y; Jiang Y; Zhang Y; Yuzyuk T; Li H; Yang Z Sci Rep; 2019 Aug; 9(1):11371. PubMed ID: 31388081 [TBL] [Abstract][Full Text] [Related]
7. Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency. Kava MP; Bryant L; Rowe P; Lewis B; Greed L; Balasubramaniam S JIMD Rep; 2020 Jul; 54(1):9-15. PubMed ID: 32685344 [TBL] [Abstract][Full Text] [Related]
8. Lysine-restricted diet and mild cerebral serotonin deficiency in a patient with pyridoxine-dependent epilepsy caused by Mercimek-Mahmutoglu S; Corderio D; Nagy L; Mutch C; Carter M; Struys E; Kyriakopoulou L Mol Genet Metab Rep; 2014; 1():124-128. PubMed ID: 27896080 [TBL] [Abstract][Full Text] [Related]
9. Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome. Coughlin CR; van Karnebeek CD; Al-Hertani W; Shuen AY; Jaggumantri S; Jack RM; Gaughan S; Burns C; Mirsky DM; Gallagher RC; Van Hove JL Mol Genet Metab; 2015; 116(1-2):35-43. PubMed ID: 26026794 [TBL] [Abstract][Full Text] [Related]
10. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency. Coughlin CR; Tseng LA; Abdenur JE; Ashmore C; Boemer F; Bok LA; Boyer M; Buhas D; Clayton PT; Das A; Dekker H; Evangeliou A; Feillet F; Footitt EJ; Gospe SM; Hartmann H; Kara M; Kristensen E; Lee J; Lilje R; Longo N; Lunsing RJ; Mills P; Papadopoulou MT; Pearl PL; Piazzon F; Plecko B; Saini AG; Santra S; Sjarif DR; Stockler-Ipsiroglu S; Striano P; Van Hove JLK; Verhoeven-Duif NM; Wijburg FA; Zuberi SM; van Karnebeek CDM J Inherit Metab Dis; 2021 Jan; 44(1):178-192. PubMed ID: 33200442 [TBL] [Abstract][Full Text] [Related]
11. The Effects of a Single Oral Dose of Pyridoxine on Alpha-Aminoadipic Semialdehyde, Piperideine-6-Carboxylate, Pipecolic Acid, and Alpha-Aminoadipic Acid Levels in Pyridoxine-Dependent Epilepsy. Wang J; Xue J; Gong P; Wu M; Yang W; Jiang S; Wu Y; Jiang Y; Zhang Y; Yuzyuk T; Li H; Yang Z Front Pediatr; 2019; 7():337. PubMed ID: 31508398 [No Abstract] [Full Text] [Related]
12. Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE). Pena IA; Marques LA; Laranjeira ÂB; Yunes JA; Eberlin MN; MacKenzie A; Arruda P Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):121-128. PubMed ID: 27615426 [TBL] [Abstract][Full Text] [Related]
13. A novel method for simultaneous quantification of alpha-aminoadipic semialdehyde/piperideine-6-carboxylate and pipecolic acid in plasma and urine. Yuzyuk T; Liu A; Thomas A; Wilson JE; De Biase I; Longo N; Pasquali M J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():145-152. PubMed ID: 26970849 [TBL] [Abstract][Full Text] [Related]
14. Normal plasma pipecolic acid level in pyridoxine dependent epilepsy due to ALDH7A1 mutations. Mercimek-Mahmutoglu S; Donner EJ; Siriwardena K Mol Genet Metab; 2013; 110(1-2):197. PubMed ID: 23683770 [No Abstract] [Full Text] [Related]
15. Current knowledge for pyridoxine-dependent epilepsy: a 2016 update. Pena IA; MacKenzie A; Van Karnebeek CDM Expert Rev Endocrinol Metab; 2017 Jan; 12(1):5-20. PubMed ID: 30058881 [TBL] [Abstract][Full Text] [Related]
16. A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency. Al-Shekaili HH; Petkau TL; Pena I; Lengyell TC; Verhoeven-Duif NM; Ciapaite J; Bosma M; van Faassen M; Kema IP; Horvath G; Ross C; Simpson EM; Friedman JM; van Karnebeek C; Leavitt BR Hum Mol Genet; 2020 Nov; 29(19):3266-3284. PubMed ID: 32969477 [TBL] [Abstract][Full Text] [Related]
17. Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy. Engelke UF; van Outersterp RE; Merx J; van Geenen FA; van Rooij A; Berden G; Huigen MC; Kluijtmans LA; Peters TM; Al-Shekaili HH; Leavitt BR; de Vrieze E; Broekman S; van Wijk E; Tseng LA; Kulkarni P; Rutjes FP; Mecinović J; Struys EA; Jansen LA; Gospe SM; Mercimek-Andrews S; Hyland K; Willemsen MA; Bok LA; van Karnebeek CD; Wevers RA; Boltje TJ; Oomens J; Martens J; Coene KL J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34138754 [TBL] [Abstract][Full Text] [Related]
18. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Stockler S; Plecko B; Gospe SM; Coulter-Mackie M; Connolly M; van Karnebeek C; Mercimek-Mahmutoglu S; Hartmann H; Scharer G; Struijs E; Tein I; Jakobs C; Clayton P; Van Hove JL Mol Genet Metab; 2011; 104(1-2):48-60. PubMed ID: 21704546 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC-MS/MS for pyridoxine-dependent seizures and folinic acid-responsive seizures. Sadilkova K; Gospe SM; Hahn SH J Neurosci Methods; 2009 Oct; 184(1):136-41. PubMed ID: 19631689 [TBL] [Abstract][Full Text] [Related]